Corrective and Preventive Action

Slides:



Advertisements
Similar presentations
Checking & Corrective Action
Advertisements

Radiopharmaceutical Production
ONIT Consulting LLC Who’s on your project? Q9 Initiative Presented by: Anna Gabara.
Findings/Analysis/CAPs
Understanding the Requirements Qimpro Standards Organization
FDA Warning Letter CAPA September 2010 Dr. Guido Heinrichs.
Corrective & Preventive Action Programme l Corrective and preventive action managed by one programme l Closely linked to the internal audit programme l.
Sandia is a multi-program laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy’s National Nuclear.
22000 Food Safety Management Systems
Overview Lesson 10,11 - Software Quality Assurance
Effective CAPA Program, a Valuable Tool in Quality Improvement Dharmi Trivedi.
21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.
OHT 17.1 Galin, SQA from theory to implementation © Pearson Education Limited 2004 Corrective and preventive actions — definitions The corrective and preventive.
Supplier Overview of Johnson & Johnson MD&D Supplier Quality Standard Operating Procedures (SOPs) Supplier Responsibilities for Failure Investigations.
CDRH Software Regulation
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
ISO 9000 Certification ISO 9001 and ISO
4. Quality Management System (QMS)
Training.
4. Quality Management System (QMS)
How to Implement, Process and Administer the Preventive Action Process
Preventive Action Training
Supplier Overview of Johnson & Johnson MD&D Supplier Quality Standard Operating Procedures (SOPs) Supplier Business Reviews.
Five Star Quality Consultants Implementing ISO 9001 Corrective and Preventive Action.
EHS Management System Elements
QSIT Management Controls QSIT Workshops. Management Controls u Importance u Assessment u Demonstration of Compliance.
1 European Conference on Training Strategies Kieran Cox -NSAI Education & Promotion-
Environmental Management System: Corrective and Preventive Action August 2005.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
1 Effective Safety & Health Assessments: Audits and Inspections Disclaimer: These safety materials, resources and PowerPoint ® presentations are not intended.
Top 10 Medical Device Citations
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Creating a Risk-Based CAPA Process
Building Quality Assurance into Clinical Trials. Objectives for Today: Define Quality in Research Describe How to Initiate Corrective and Preventative.
Kimberly A. Trautman FDA’s Medical Device Quality System Expert
1 Thank you for visiting our site and welcome to the “Introduction to ISO 22000” Presentation that you requested. For more information.
CAPA, Root Cause Analysis, and Risk Management
ISO NON-CONFORMANCE, CORRECTIVE AND PREVENTIVE ACTION.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
ISO, QMS & CIR Awareness 2013.
INSPECTION AND ACCEPTANCE CRITERIA. PRODUCT CONFORMANCE Dimensional conformance - within tolerances as defined on product drawing Dimensional conformance.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
A QUALITY IMPROVEMENT TOOL
Software Quality Assurance SOFTWARE DEFECT. Defect Repair Defect Repair is a process of repairing the defective part or replacing it, as needed. For example,
ISO Registration Common Areas of Nonconformances.
1 Beth Staub and Joseph Sapiente FDA Case for Quality.
Chapter 19 Manufacturing and Quality Control
AWARENESS OF HEALTH AND SAFETY IN THE WORKPLACE-A CASE AT AKUH, N Joshua Odero, Zahir Moloo, Zul Premji Department of Pathology, Aga Khan University Hospital,
1 QUALITY MANAGEMENT SYSTEM PRESENTATION TO BOTSWANA DRUG ADVISORY BOARD MEMBERS 13 th – 17 th AUGUST 2007.
GMP Regulatory Perspective Dr. Pooja Mahadev Shirodkar Wallace Pharmaceuticals Pvt. Ltd. Date:
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
ITRI Industrial Technology Research Institute The Audit Process of Medical Device GMP for Domestic Manufacturers DOH Designated Auditing Organizations.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Root Cause Analysis Roger Brauninger
UNDERSTANDING ISO 9001:2008.
Implementing a Successful Corrective and Preventative Action Program
Documentation control
External Validation of Quality Programs
KMCO CAPA System Training
Air Carrier Continuing Analysis and Surveillance System (CASS)
Director, Quality and Accreditation
The Quality System Inspection Technique (QSIT)
FDA Quality System Regulation
ISO 9000 Dr. S. Thomas Foster, Jr..
External Validation of Quality Programs
Radiopharmaceutical Production
CAPA, Root Cause Analysis, and Risk Management
Supplier Corrective ACTION RESPONSE REVIEW TRAINING
Presentation transcript:

Corrective and Preventive Action By Superlative BioSciences Corporation October 13, 2007

What is CAPA? Corrective and Preventative Action (CAPA) is a system of quality procedures required to eliminate the causes of an existing nonconformity and to prevent recurrence of nonconforming product, processes, and other quality problems.

Regulatory Guidance “Corrective and Preventive Action,” Quality System Regulation (QSR), 21 CFR Part 820, Medical Devices, Subpart J, Sec. 100, Became effective on June 1, 1997, Replacing the 1978 GMP for Medical Devices. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=820 “Overview of the Quality System Regulation for Medical Devices,” Kimberly Trautman – Food and Drug Administration, USA and Chair, Study Group 3, June 29, 1999. http://www.fda.gov/cdrh/reuse/events/cdrom-9.ppt “QSIT Corrective & Preventive Actions,” Quality System Inspection Techniques (QSIT) Guide, August 1999. http://www.fda.gov/ora/inspect_ref/igs/qsit/qsitguide.pdf “Establishment and Maintenance of a Quality Program.” Human Cells, Tissues, And Cellular And Tissue-Based Products (HCT/P's), 21 CFR Part 1271 Subpart D, Current Good Tissue Practice (cGTP), Sec. 160, May 25, 2004. Revised as of April 1, 2006, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271

Terminology Nonconforming Material or Process (Discrepancy) - Any material or process that does not meet its required specifications or documented procedure. Correction – Refers to repair, rework, or adjustment and relates to the disposition of an existing nonconformity. Corrective Action - To identify and eliminate the causes of existing nonconforming product and other quality problems. Preventive Action - To identify and eliminate the causes of potential nonconforming product and other quality problems.

Seven Quality Subsystems

Components Of Corrective And Preventive Action (CAPA) Collect and analyze data to identify nonconforming product and other quality problems Investigate cause Identify and implement corrective and preventive action Verify or validate effectiveness

Components Of Corrective And Preventive Action (CAPA) Communicate information about quality problems, changes made, outcomes, and trends to those persons directly responsible and to the staff in general Forward information for management review Work with staff and management to produce continuous quality improvement

Quality Data Sources

CAPA Case Studies Weak CA, Weak PA (Common) Weak CA, Strong PA (Unusual) Strong CA, Weak or Unlinked PA (Common) Strong PA Linked to a Strong CA (Ideal)

Case Study No. 1 The company develops biopharmaceuticals The company has a CAPA program A review of existing internal and external audits reveal that: nonconformities are documented corrections are proposed (a temporary or permanent change, repair, rework, or scrap) corrections made are timely but the same nonconformities seem to reoccur over and over again customers are complaining

The current investigation indicates that: nonconformities are not adequately categorized and trended the root causes of existing nonconformities are not adequately investigated or addressed preventive actions are not sufficient to eliminate the reoccurrence of the nonconformity discrepancy and CAPA procedures are not well-written or difficult to follow the forms utilized don’t follow the flow of the procedure the forms do not provide enough space for more than a brief entry verbal decisions are not written down responsible people are assigned but a timelines for the follow-ups is not given or is vague

The Solution Revise all Quality Assurance Procedures to emphasize CAPA and to link discrepancy reporting and disposition to preventive action Initiate a trending and root cause analysis program Present these programs to management and to the staff Revise the nonconformity, CA, and PA forms Conduct formal CAPA training Reinforce CAPA awareness in verbal communications Provide a “Quality Update” at the company’s monthly staff meeting

The Results Easier to follow quality procedures More user-friendly forms A better understanding of processes obtained through root cause analysis More proactive thinking vs. reactive thinking Fewer nonconformities Less scrap and rework Fewer customer complaints

Pre-CAPA Post-CAPA Post-CAPA

Thank you